OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
Executive Summary
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
You may also be interested in...
US FDA Panel Sees Benefits To OTC Pathogen Tests, But Urges Caution
An FDA panel concluded Aug. 16 that the benefits of over-the-counter tests for influenza, strep throat and certain sexually transmitted infections would likely outweigh the risks. But the group urged developers to take care in ensuring that the test results were easy for patients to interpret.
OraSure Preps October Launch Of First-Ever In-Home HIV Test
Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.